A total of 1 analyst ratings have been received for AngioDynamics, with the consensus rating being Buy. The average one-year price target stands at $15.0, suggesting a potential 59.74% upside.

The following is a summary of "A new guiding strategy for treating the free margin of the leaflet in an aortic root ...

TransMedics' NOP advances organ transplantation with improved outcomes & cost reductions. See why I rate TMDX stock a strong ...

Surgical Intervention for Gastrointestinal Foreign Bodies in Adult Patients: A Case Series. Surgical Science, 16, 182-193.

The incredibly high profit margins and perfect balance sheet as well as energy exposure that we didn't have in the MaM ...

Negative surgical margins regardless of surgery type was associated with increased overall survival in patients with Merkel cell carcinoma.

As an investor, if you are uncomfortable with the risks and high valuation, there are two stocks well-positioned to be more ...

This story is part of your SHN+ subscription Senior living companies are evolving their operating models to increasingly use new technology and real-time ...

Alcon is one of the leading visioncare companies in the world, with a record of successful product development, and it will continue to launch technically superior products.

Minneapolis-based Allina Health reported an operating loss of $16.6 million (-0.3% margin) for the year ended Dec. 31, 2024, ...

Net Margin: Staar Surgical's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -69.92%, the company may face hurdles in ...

Without allocations, the median operating margin grew to 8% ... outpaced outpatient revenue growth (3%), reflecting more surgical and emergency department visits leading to extended stays.